Relay Therapeutics Inc (RLAY)

EBITDA Margin

-23813.43%

Quarterly · Period ending:

RLAY logo

RLAY EBITDA Margin

Latest reported-23813.43%
RLAY Quarterly EBITDA Margin (0.00% → -23813.43%)
High-resolution chart · PNG

RLAY ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-23,813.4286%
-2,426.2333%
-775.5857%
0%
-10,247.1196%
-987.85%
0%
0%
0%
-907.3648%
9,288,800%
-291.3023%
-89,805.042%
-44,682.7434%
-32,501.581%
-23,720.0581%
-21,001.3699%
-15,833.1742%
-11,455.5554%
-8,705.4054%
-6,844.1943%
-4,357.7731%
43.7825%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.